Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management

Cancer
Daniel CourielKrishna V Komanduri

Abstract

Hematopoietic stem cell transplantation has evolved as a central treatment modality in the management of different hematologic malignancies. Despite adequate posttransplantation immunosuppressive therapy, acute graft-versus-host disease (GVHD) remains a major cause of morbidity and mortality in the hematopoietic stem cell transplantation setting, even in patients who receive human leukemic antigen (HLA) identical sibling grafts. Up to 30% of the recipients of stem cells or bone marrow transplantation from HLA-identical related donors and most patients who receive cells from other sources (matched-unrelated, non-HLA-identical siblings, cord blood) will develop > Grade 2 acute GVHD despite immunosuppressive prophylaxis. Thus, GVHD continues to be a major limitation to successful hematopoietic stem cell transplantation. In this review, the authors summarize the most current knowledge on the pathophysiology, clinical manifestations, and management of this potentially life-threatening transplantation complication.

References

Dec 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·C QueenT A Waldmann
Sep 26, 1985·The New England Journal of Medicine·P G BeattyR Storb
Jun 1, 1993·International Immunology·C S Via, F D Finkelman
Mar 1, 1996·Current Opinion in Oncology·J Gajewski, R Champlin
Dec 22, 1998·The Journal of Experimental Medicine·S A Kalams, B D Walker
Dec 22, 1998·The Journal of Experimental Medicine·A J ZajacR Ahmed
Jun 3, 1999·The New England Journal of Medicine·E C GuinanJ G Gribben
Dec 1, 1999·Bone Marrow Transplantation·D PrzepiorkaJ Wingard
Mar 17, 2000·Leukemia·G B Vogelsang
Nov 22, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·P A CarpenterC Anasetti
Nov 30, 2000·The American Journal of Gastroenterology·N IqbalC M Wilcox
Mar 22, 2001·British Journal of Haematology·W WillenbacherM G Kiehl
Mar 29, 2001·Experimental Hematology·H GokerN J Chao
Apr 20, 2001·Critical Reviews in Oncology/hematology·N BasaraA A Fauser
Jul 5, 2001·Bone Marrow Transplantation·H KhouryJ F DiPersio
Aug 16, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C CutlerJ H Antin
Aug 18, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·C WasemT Brunner
Apr 4, 2002·Drugs·David A Jacobsohn, Georgia B Vogelsang
Apr 10, 2002·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Sally AraiGeorgia B Vogelsang
May 2, 2002·Journal of Hematotherapy & Stem Cell Research·Sally AraiGeorgia B Vogelsang
Aug 7, 2002·The Journal of Experimental Medicine·José L CohenBenoît L Salomon
Oct 3, 2002·Annual Review of Medicine·Georgia B VogelsangDebra M Bensen-Kennedy
Oct 24, 2002·Blood·Görgün AkpekGeorgia B Vogelsang

❮ Previous
Next ❯

Citations

Feb 1, 2011·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·R TravnikS Karrer
Jan 12, 2010·Cardiovascular and Interventional Radiology·Joshua L WeintraubRobert L Lookstein
May 26, 2005·Current Treatment Options in Gastroenterology·William A Ross
Jun 2, 2010·International Journal of Hematology·Joo Han LimSun U Song
Jul 24, 2008·Bone Marrow Transplantation·L M BallUNKNOWN EBMT Paediatric Working Party
Feb 10, 2007·Bone Marrow Transplantation·S HingoraniG B McDonald
Sep 30, 2005·The New England Journal of Medicine·Gérard Socié
May 22, 2010·Cornea·Arnaud C WestenengAniki Rothova
Nov 10, 2009·Transplantation·David GhezAgnès Buzyn
Jan 18, 2006·Annual Review of Medicine·David A Randolph, C Garrison Fathman
Jun 23, 2006·Drugs·José A Pérez-SimónJesús San Miguel
May 16, 2014·Transplantation·Julie AbrahamGérard Socié
Dec 29, 2011·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·G Stephen MorrisMarcos J de Lima
Nov 24, 2011·Advances in Hematology·Jason R WestinDaniel R Couriel
Nov 26, 2008·Bone Marrow Transplantation·L M BallR M Egeler
Jan 31, 2008·Dermatology : International Journal for Clinical and Investigative Dermatology·Peter HäusermannAlois Gratwohl
Mar 1, 2012·Journal of Pediatric Gastroenterology and Nutrition·Mutaz SultanSteven Werlin
Aug 7, 2009·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Sinem Civriz BozdagMuhit Ozcan
Aug 11, 2006·Current Opinion in Ophthalmology·Stella K Kim
Mar 31, 2010·Leukemia & Lymphoma·Charulata RamaprasadDavid L Pitrak
Sep 6, 2013·Immunological Investigations·Margarita PesmatzoglouEftichia Stiakaki
May 19, 2010·Expert Review of Clinical Immunology·Susan E Conway, Reza Abdi
Apr 2, 2013·Survey of Ophthalmology·Hasanain ShikariReza Dana
Jul 31, 2012·Transplantation Proceedings·M YilmazS Yilmaz
Dec 3, 2014·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Divaya BhutaniJoseph P Uberti
May 19, 2009·Emergency Medicine Clinics of North America·David E Adelberg, Michael R Bishop
Dec 12, 2007·Seminars in Cutaneous Medicine and Surgery·Steven R MaysSharon R Hymes
Dec 25, 2007·Dental Clinics of North America·Mark M Schubert, Maria Elvira Pizzigatti Correa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
Alexandra H FilipovichMary E D Flowers
Hematology/oncology Clinics of North America
Mary E D FlowersK M Sullivan
The New England Journal of Medicine
J L Ferrara, H Joachim Deeg
© 2021 Meta ULC. All rights reserved